BAAM
ALXN

Baker Avenue Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Baker Avenue Asset Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,750
Closed -$429K – 248
2020
Q3 		$429K Buy
+3,750
New +$429K 0.03% 173